Canterbury DHB
ET is a chronic, slowly progressive disease, and thus any intervention needs to carry minimum risk to the patient. The following table reflects this conservative approach.
See Campbell PJ, Green AR (2005),3 table 4 for recommendations for management of patients with ET.
For current trials in ET, check the Clintrial NZ app or phone the Clinical Trials Co-ordinator (ext: 80377).
Topic Code: 6238